226 related articles for article (PubMed ID: 15868445)
1. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
Barnes PJ; Boutilier R; Chiasson D; Rayson D
Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
3. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
4. Metaplastic breast carcinoma: a cytohistologic and clinical study of 10 cases.
Johnson TL; Kini SR
Diagn Cytopathol; 1996 May; 14(3):226-32. PubMed ID: 8732652
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
[TBL] [Abstract][Full Text] [Related]
6. Study of HER2/neu status in Qatari women with breast carcinoma.
Rasul KI; Mohammaed K; Abdalla AS; Chong-Lopez A; Ahmad MA; Al-Homsi MU; Al-Hassan AM; Al-Alosi AS; Bener A
Saudi Med J; 2003 Aug; 24(8):832-6. PubMed ID: 12939666
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER2/neu in primary and metastatic breast cancer.
Tuziak T; Olszewski WP; Olszewski W; Pieńkowski T
Pol J Pathol; 2001; 52(1-2):21-6. PubMed ID: 11505677
[TBL] [Abstract][Full Text] [Related]
8. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.
Gobbi H; Simpson JF; Jensen RA; Olson SJ; Page DL
Mod Pathol; 2003 Sep; 16(9):893-901. PubMed ID: 13679453
[TBL] [Abstract][Full Text] [Related]
9. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
[TBL] [Abstract][Full Text] [Related]
10. Cytophotometric measurements of metaplastic carcinoma of the breast: correlation with pathologic features and clinical behavior.
Flint A; Oberman HA; Davenport RD
Mod Pathol; 1988 May; 1(3):193-7. PubMed ID: 3237700
[TBL] [Abstract][Full Text] [Related]
11. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
Leers MP; Hoop JG; Nap M
Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
[TBL] [Abstract][Full Text] [Related]
12. A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.
Lu D; Masood S; Khalbuss WE; Bui M
Cancer; 2002 Oct; 96(5):294-300. PubMed ID: 12378597
[TBL] [Abstract][Full Text] [Related]
13. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
Coyne JD; Dervan PA; Barr L
Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.
Moriki T; Takahashi T; Ueta S; Mitani M; Ichien M
Diagn Cytopathol; 2004 Apr; 30(4):251-6. PubMed ID: 15048960
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
16. Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas.
Popnikolov NK; Ayala AG; Graves K; Gatalica Z
Am J Clin Pathol; 2003 Aug; 120(2):161-7. PubMed ID: 12931544
[TBL] [Abstract][Full Text] [Related]
17. Spindle cell carcinoma of the breast, a mimicker of benign lesions: case report and review of the literature.
Al-Bozom IA; Abrams J
Arch Pathol Lab Med; 1996 Nov; 120(11):1066-8. PubMed ID: 12049111
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
[TBL] [Abstract][Full Text] [Related]
19. Primary combined malignant melanoma and ductal carcinoma of the breast. A report of two cases.
Padmore RF; Lara JF; Ackerman DJ; Gales T; Sigurdson ER; Ehya H; Cooper HS; Patchefsky AS
Cancer; 1996 Dec; 78(12):2515-25. PubMed ID: 8952560
[TBL] [Abstract][Full Text] [Related]
20. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases.
Kardon DE; Thompson LD; Przygodzki RM; Heffess CS
Mod Pathol; 2001 May; 14(5):443-51. PubMed ID: 11353055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
